VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Wednesday, January 7, 2026

Wide Moat Stocks Expansion-Stage Stocks Home My Collections

Stock Comparison

Brookfield Corporation vs Cochlear Limited

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Brookfield Corporation

BN · New York Stock Exchange

Market cap (USD)$109.6B

Gross margin (TTM)34.5%

Operating margin (TTM)24.1%

Net margin (TTM)1.3%

SectorFinancials

IndustryAsset Management

CountryCA

Data as of2026-01-05

Moat score

65/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Brookfield Corporation's moat claims, evidence, and risks.

View BN analysis

Cochlear Limited

COH · ASX

Market cap (USD)$17B

Gross margin (TTM)74.5%

Operating margin (TTM)22.7%

Net margin (TTM)16.2%

SectorHealthcare

IndustryMedical - Devices

CountryAU

Data as of2026-01-04

Moat score

81/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Cochlear Limited's moat claims, evidence, and risks.

View COH analysis

Comparison highlights

Moat score gap: Cochlear Limited leads (81 / 100 vs 65 / 100 for Brookfield Corporation).
Segment focus: Brookfield Corporation has 6 segments; Cochlear Limited has 3 segments (62.4% in Cochlear Implants).
Moat breadth: Brookfield Corporation has 10 moat types across 5 domains; Cochlear Limited has 8 across 3.

Primary market context

Brookfield Corporation

Asset Management

Market

Alternative asset management (private markets: infrastructure, renewables, private equity, real estate, credit)

Geography

Global

Customer

Institutional investors and private wealth channels

Role

General partner (GP) / asset manager

Cochlear Limited

Cochlear Implants

Market

Cochlear implant systems (internal implant + external sound processors) for severe-to-profound hearing loss

Geography

Global

Customer

Hospitals/ENT clinics and audiology programs (providers) serving implant candidates/recipients; reimbursed by public/private payers

Role

Medical device OEM / platform owner (implant + processor + fitting software + clinical support)

Revenue share

62.4%

Side-by-side metrics

Brookfield Corporation

Cochlear Limited

Ticker / Exchange

BN - New York Stock Exchange

COH - ASX

Market cap (USD)

$109.6B

$17B

Gross margin (TTM)

34.5%

74.5%

Operating margin (TTM)

24.1%

22.7%

Net margin (TTM)

1.3%

16.2%

Sector

Financials

Healthcare

Industry

Asset Management

Medical - Devices

HQ country

Primary segment

Asset Management

Cochlear Implants

Market structure

Oligopoly

Market share

n/a

60%-65% (reported)

HHI estimate

n/a

Pricing power

Moderate

Moat score

65 / 100

81 / 100

Moat domains

Demand, Network, Financial, Supply, Legal

Demand, Legal, Supply

Last update

2026-01-05

2026-01-04

Moat coverage

Shared moat types

Brand TrustCapex Knowhow Scale

Brookfield Corporation strengths

Long Term ContractsEcosystem ComplementsFloat PrepaymentCost Of Capital AdvantagePermits Rights Of WayPhysical Network DensityOperational ExcellenceGeographic Natural

Cochlear Limited strengths

Compliance AdvantageIP Choke PointService Field NetworkInstalled Base ConsumablesFormat Lock InData Workflow Lockin

Segment mix

Brookfield Corporation segments

Full profile >

Asset Management

Oligopoly

n/a

Wealth Solutions (Insurance)

Competitive

n/a

Renewable Power and Transition

Competitive

n/a

Infrastructure

Oligopoly

n/a

Private Equity (Operating Businesses)

Competitive

n/a

Real Estate

Competitive

n/a

Cochlear Limited segments

Full profile >

Cochlear Implants

Oligopoly

62.4%

Services

Monopoly

25.9%

Acoustics

Oligopoly

11.7%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.